Inversago
acquired by Novo Nordisk4 known investors
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Investors · 4
Frequently asked questions
- What does Inversago do?
- Portfolio company acquired by Novo Nordisk for $1.1B USD.
- Who are Inversago's investors?
- Inversago's investors include AmorChem, Genesys Capital, JDRF T1D Fund, Tarnagulla Ventures.
- Who acquired Inversago?
- Inversago was acquired by Novo Nordisk.